New Delhi/Hyderabad: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with SARS-CoV 2 vaccines. India is yet to approve the use of intranasal COVID-19 vaccine BBV154 developed by the Hyderabad-based company. Drugs Controller General of […]
